Kendacare: Disrupting the UK snack market with healthy, convenient and delicious personalised-nutrition

Kendacare:以健康、方便、美味的个性化营养颠覆英国零食市场

基本信息

  • 批准号:
    10074440
  • 负责人:
  • 金额:
    $ 71.45万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Collaborative R&D
  • 财政年份:
    2023
  • 资助国家:
    英国
  • 起止时间:
    2023 至 无数据
  • 项目状态:
    未结题

项目摘要

There is a growing burden from diet-related disease within the UK, leading to severe healthcare cost inflation as increasing numbers become affected. Poor diet is a significant factor, today attributable to 9% of all NHS spend\[1\].Since 2011, the UK has experienced a halt in overall life-expectancy gains, with a widening gap between rich and poor\[2\]. Under-50s in the UK are experiencing increased 'avoidable deaths'\[3\], while the UK's obesity-rate is among the worlds' highest\[4\]. These challenges have been exacerbated by the dominance of unhealthy, high in fat, sugar, salt and additives (HFSS) snacks. These 'convenience-snacks', an £11-billion-per-year industry in the UK\[5\], offer an easy-to-find, tempting and affordable option for a time-poor, stressed, on-the-go UK adult-population, are a leading cause of unhealthy diets among the mainstream population, leading to severe health-issues including obesity, diabetes, high-cholesterol and cardiovascular-disease.KNC will disrupt the convenience-snack market by developing a nutritious, delicious, inclusive and affordable food-supplement unlike anything available in the UK today. 'Kendacare', an ambient food-supplement, consumable as a shake or everyday-meal supplement, will be the first food-supplement range with personalised-formulations designed to address several stratified nutritional needs and health-challenges of the aged 25-50 adults in the UK; beginning with obesity, diabetes, high-cholesterol and healthy-joints. The Kendacare range will come in both dairy and plant-based formats and in a variety of delicious flavours, empowering healthier-habits within UK adult diets and reducing food-waste.Kendacare is an ambitious project that will include detailed market-research and expert-collaboration to develop stratified, bespoke recipes that proactively-address the most pressing health-issues impacting UK-adults today. The project will comprise several technical challenges, from incorporating novel natural ingredients (minimally-processed, stability-controlled and all UK-sourced), to incorporating innovative manufacturing steps (milk-fractionation), to delivering enhanced-nutrition in a format that is tasty, convenient, inclusive, accessible and affordable for UK-adults. Development of Kendacare will comprise a 30-month project involving R&D, quality, production and regulatory challenges never-before-overcome in our industry, necessitating research, analysis and process-innovation to deliver the ambitious taste, nutritional, shelf-stability, convenience and sustainability targets.Successful development and commercialisation of a novel, nutritionally-superior and regulatory-accredited food-supplement known to address key UK health-issues, will stimulate a proactive, preventative approach to UK-health, helping address the urgent-challenges of diet-related-diseases, gut-microbiota development, sugar-level regulation and mental-health, while delivering significant domestic revenue, export potential, local job-creation, re-investment in UK agriculture and a reduced burden on the NHS and wider UK-economy.\[1\]-NHS-England:-NHSPrevention-Programme-cutschances-of-Type-2-diabetes-for-thousands\[2\]Marshall-et-al.-Mortality-and-life-expectancy-trends-in-the-UK:-Stalling-progress.-The-Health-Foundation;-2019\[3\]UK-Attitude-Towards-eating-Healthy-Market-report-2022-(Mintel)\[4\]-WHO-EUROPEAN-REGIONAL-OBESITY-REPORT-2022\[5\]-BCC-Research-Global-Snack-Food-Market-Size-Scope-And-Forecast-(2020)
在英国,饮食相关疾病的负担越来越重,随着越来越多的人受到影响,导致严重的医疗保健成本上涨。不良的饮食习惯是一个重要的因素,今天占所有NHS支出的9%。自2011年以来,英国的总体预期寿命增长已经停止,贫富差距扩大。英国50岁以下的人正在经历越来越多的“可避免的死亡”,而英国的肥胖率是世界上最高的。这些挑战因不健康、高脂肪、高糖、高盐和高添加剂(HFSS)零食的主导地位而加剧。这些“减肥零食”在英国是一个每年110亿英镑的产业,为时间紧迫、压力大、忙碌的英国成年人提供了一个容易找到、诱人且负担得起的选择,是主流人群不健康饮食的主要原因,导致严重的健康问题,包括肥胖、糖尿病、高胆固醇和心血管疾病。KNC将通过开发一种营养丰富,美味,包容性和负担得起的食品补充剂来扰乱减肥零食市场,这与当今英国的任何产品都不同。“Kendacare”是一种环境食品补充剂,可作为奶昔或日常膳食补充剂食用,将是第一个具有个性化配方的食品补充剂系列,旨在解决英国25-50岁成年人的几个分层营养需求和健康挑战;从肥胖,糖尿病,高胆固醇和健康关节开始。Kendacare系列将以乳制品和植物为基础的形式以及各种美味的口味,在英国成人饮食中赋予健康的习惯并减少食物浪费。Kendacare是一个雄心勃勃的项目,将包括详细的市场研究和专家合作,以开发分层,定制的食谱,主动解决当今影响英国成年人的最紧迫的健康问题。该项目将包括几个技术挑战,从采用新型天然成分(最小加工,稳定性控制和所有英国来源),到采用创新的制造步骤(牛奶分馏),再到以美味,方便,包容,可获得和负担得起的形式为英国成年人提供增强营养。Kendacare的开发将包括一个为期30个月的项目,涉及我们行业从未克服的研发、质量、生产和监管挑战,需要研究、分析和工艺创新,以实现雄心勃勃的口味、营养、货架稳定性、便利性和可持续性目标。营养优越和监管认证的食品补充剂,已知解决关键的英国健康问题,将刺激积极的,预防性的方法,以英国健康,帮助解决紧迫的挑战,饮食相关的疾病,肠道微生物群的发展,糖水平的监管和心理健康,同时提供显着的国内收入,出口潜力,创造当地就业机会,对英国农业的再投资,并减轻NHS和更广泛的英国经济的负担。[1]-NHS-英格兰:-NHS预防计划-切割2型糖尿病-数千人\[2\]马歇尔等人-英国死亡率和预期寿命趋势:-进展停滞。-健康基金会;-2019年\月3日\]英国-对健康饮食的态度-市场-报告-2022年-(英敏特)\[4\]-世界卫生组织-欧洲-区域-肥胖-报告-2022年\[5\]-BCC-研究-全球-零食-食品-市场-规模-范围-和-预测-(2020年)

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

其他文献

吉治仁志 他: "トランスジェニックマウスによるTIMP-1の線維化促進機序"最新医学. 55. 1781-1787 (2000)
Hitoshi Yoshiji 等:“转基因小鼠中 TIMP-1 的促纤维化机制”现代医学 55. 1781-1787 (2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
LiDAR Implementations for Autonomous Vehicle Applications
  • DOI:
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
生命分子工学・海洋生命工学研究室
生物分子工程/海洋生物技术实验室
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
吉治仁志 他: "イラスト医学&サイエンスシリーズ血管の分子医学"羊土社(渋谷正史編). 125 (2000)
Hitoshi Yoshiji 等人:“血管医学与科学系列分子医学图解”Yodosha(涉谷正志编辑)125(2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Effect of manidipine hydrochloride,a calcium antagonist,on isoproterenol-induced left ventricular hypertrophy: "Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,K.,Teragaki,M.,Iwao,H.and Yoshikawa,J." Jpn Circ J. 62(1). 47-52 (1998)
钙拮抗剂盐酸马尼地平对异丙肾上腺素引起的左心室肥厚的影响:“Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:

的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('', 18)}}的其他基金

An implantable biosensor microsystem for real-time measurement of circulating biomarkers
用于实时测量循环生物标志物的植入式生物传感器微系统
  • 批准号:
    2901954
  • 财政年份:
    2028
  • 资助金额:
    $ 71.45万
  • 项目类别:
    Studentship
Exploiting the polysaccharide breakdown capacity of the human gut microbiome to develop environmentally sustainable dishwashing solutions
利用人类肠道微生物群的多糖分解能力来开发环境可持续的洗碗解决方案
  • 批准号:
    2896097
  • 财政年份:
    2027
  • 资助金额:
    $ 71.45万
  • 项目类别:
    Studentship
A Robot that Swims Through Granular Materials
可以在颗粒材料中游动的机器人
  • 批准号:
    2780268
  • 财政年份:
    2027
  • 资助金额:
    $ 71.45万
  • 项目类别:
    Studentship
Likelihood and impact of severe space weather events on the resilience of nuclear power and safeguards monitoring.
严重空间天气事件对核电和保障监督的恢复力的可能性和影响。
  • 批准号:
    2908918
  • 财政年份:
    2027
  • 资助金额:
    $ 71.45万
  • 项目类别:
    Studentship
Proton, alpha and gamma irradiation assisted stress corrosion cracking: understanding the fuel-stainless steel interface
质子、α 和 γ 辐照辅助应力腐蚀开裂:了解燃料-不锈钢界面
  • 批准号:
    2908693
  • 财政年份:
    2027
  • 资助金额:
    $ 71.45万
  • 项目类别:
    Studentship
Field Assisted Sintering of Nuclear Fuel Simulants
核燃料模拟物的现场辅助烧结
  • 批准号:
    2908917
  • 财政年份:
    2027
  • 资助金额:
    $ 71.45万
  • 项目类别:
    Studentship
Assessment of new fatigue capable titanium alloys for aerospace applications
评估用于航空航天应用的新型抗疲劳钛合金
  • 批准号:
    2879438
  • 财政年份:
    2027
  • 资助金额:
    $ 71.45万
  • 项目类别:
    Studentship
Developing a 3D printed skin model using a Dextran - Collagen hydrogel to analyse the cellular and epigenetic effects of interleukin-17 inhibitors in
使用右旋糖酐-胶原蛋白水凝胶开发 3D 打印皮肤模型,以分析白细胞介素 17 抑制剂的细胞和表观遗传效应
  • 批准号:
    2890513
  • 财政年份:
    2027
  • 资助金额:
    $ 71.45万
  • 项目类别:
    Studentship
CDT year 1 so TBC in Oct 2024
CDT 第 1 年,预计 2024 年 10 月
  • 批准号:
    2879865
  • 财政年份:
    2027
  • 资助金额:
    $ 71.45万
  • 项目类别:
    Studentship
Understanding the interplay between the gut microbiome, behavior and urbanisation in wild birds
了解野生鸟类肠道微生物组、行为和城市化之间的相互作用
  • 批准号:
    2876993
  • 财政年份:
    2027
  • 资助金额:
    $ 71.45万
  • 项目类别:
    Studentship

相似海外基金

Analysing and disrupting outlaw motorcycle gangs in Australia
分析和打击澳大利亚的非法摩托车团伙
  • 批准号:
    DP240100161
  • 财政年份:
    2024
  • 资助金额:
    $ 71.45万
  • 项目类别:
    Discovery Projects
Investigation of Endocrine-Disrupting Chemicals as Contributors to Progression of Metabolic Dysfunction Associated Steatotic Liver Disease (EDC-MASLD)
内分泌干​​扰化学物质对代谢功能障碍相关脂肪性肝病 (EDC-MASLD) 进展的影响的调查
  • 批准号:
    10092670
  • 财政年份:
    2024
  • 资助金额:
    $ 71.45万
  • 项目类别:
    EU-Funded
Planning: BPE TRACK 1: DISRUPTING RACIALIZED PRIVILEGE IN THE STEM CLASSROOM
规划:BPE 轨道 1:破坏 STEM 课堂上的种族化特权
  • 批准号:
    2234708
  • 财政年份:
    2023
  • 资助金额:
    $ 71.45万
  • 项目类别:
    Standard Grant
Conference and Grantee's Meeting: Disrupting Operations of Illicit Supply Networks; Arlington, Virginia; 27-28 March 2023
会议和受资助者会议:扰乱非法供应网络的运作;
  • 批准号:
    2247286
  • 财政年份:
    2023
  • 资助金额:
    $ 71.45万
  • 项目类别:
    Standard Grant
Disrupting the mosquito larval midgut using novel pH responsive compounds
使用新型 pH 响应化合物破坏蚊子幼虫中肠
  • 批准号:
    10722596
  • 财政年份:
    2023
  • 资助金额:
    $ 71.45万
  • 项目类别:
Disrupting Dogma: Investigating LPS Biosynthesis Inhibition as an Alternative Mechanism of Action of Aminoglycoside Antibiotics
颠覆教条:研究 LPS 生物合成抑制作为氨基糖苷类抗生素的替代作用机制
  • 批准号:
    10653587
  • 财政年份:
    2023
  • 资助金额:
    $ 71.45万
  • 项目类别:
D-ISN/Collaborative Research: Disrupting West Virginia's Opioid Crisis: a Multi-disciplinary Approach through Interdiction and Harm Reduction
D-ISN/合作研究:扰乱西弗吉尼亚州的阿片类药物危机:通过拦截和减少危害采取多学科方法
  • 批准号:
    2240361
  • 财政年份:
    2023
  • 资助金额:
    $ 71.45万
  • 项目类别:
    Standard Grant
Disrupting nuclear condensates and immune evasion mechanisms as a novel antiparasitic strategy
破坏核凝聚和免疫逃避机制作为一种新型抗寄生虫策略
  • 批准号:
    2889670
  • 财政年份:
    2023
  • 资助金额:
    $ 71.45万
  • 项目类别:
    Studentship
Detecting, diagnosing and disrupting schistosomiasis.
检测、诊断和消灭血吸虫病。
  • 批准号:
    2885490
  • 财政年份:
    2023
  • 资助金额:
    $ 71.45万
  • 项目类别:
    Studentship
The Impact of Disrupting Sensory Innervation on Tibial Bone Mass
破坏感觉神经对胫骨骨量的影响
  • 批准号:
    10714639
  • 财政年份:
    2023
  • 资助金额:
    $ 71.45万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了